newsfilter
← Latest News
Business Wire·

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRRK
  • Scholar Rock granted inducement equity awards covering 39,587 common stock shares to six newly hired employees.
  • The awards include inducement stock options for 11,349 shares & inducement restricted stock units for 28,238 shares.
  • The awards are subject to the Company's 2022 Inducement Equity Plan, which is used exclusively to induce non-employees or former employees to join the firm under Nasdaq Listing Rule 5635(c)(4).
  • Inducement stock options have an exercise price of $51.55, matching the closing stock price on November 9, 2026.
  • Stock option vesting occurs at 25% on the first anniversary of the start date, with the remaining 75% vesting in 12 equal quarterly installments.
  • Restricted stock unit vesting occurs in four equal annual installments, contingent on continued employment.
  • Scholar Rock is commercializing ISEMBLYD (apitegromab-mstn) in the U.S. for SMA patients aged 2+ following FDA approval in September 2026.
  • The Company plans to expand global access to ISEMBLYD in up to 50 countries, subject to regulatory approvals.